Table 2.
Urine AOG/ creatinine ratio (ng/mg) and AER (mg/24 hr) in the DCCT and EDIC study visits prior to outcome.
Cases N = 34 | Controls N = 51 | P‐value* | |
---|---|---|---|
DCCT visit. AOG/Creatinine Ratio (ng/mg) (Median and range) | 2.75 (0.38–30) | 3.16 (0.53–26) | 0.67 |
EDIC visit. AOG/Creatinine ratio (ng/mg) (Median and range) | 13.9 (0.96–989) | 3.83 (0.44–228) | 0.003 |
DCCT visit. AER (mg/24hr) (Median and range) | 10.0 (1.4–99.7) | 10.1 (4–46) | 0.61 |
EDIC visit. AER (mg/24hr) (Median and range) | 86 (4.3–7357) | 9 (3–20) | 0.01 |
Urine AOG/ creatinine (ng/mg) was measured prior to outcome (eGFR <60 mL/min per 1.73m2.) in DCCT visit (range 17‐20 years prior to outcome) and in EDIC visit (range 1–7 years prior to outcome).
Reflects the P‐value obtained as per conditional regression analysis.